Mitchell Patrick Wilson

24PUBLICATIONS

25CO-AUTHORS

Metabolic medicinePredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisNeurosciences not elsewhere classified

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (24)

Sort by Publication Date:

|Jun 26, 2026

Summary of Guidelines for Identifying and Risk-Stratifying Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Primer for Family Physicians.

|Mar 19, 2026

Further Discussion of Differences in Imaging-based Investigations for Risk Stratification of Patients with MASLD Is Warranted.

Mitchell P Wilson, Gavin Low

|Mar 03, 2026

MRI features and LI-RADS categorization of combined hepatocellular-cholangiocarcinoma: a scoping review with prognostic implications.

Xu Jing Qian, Ali Ramji, Karim Samji

|Jan 28, 2026

An Updated Review of Combined Hepatocellular Cholangiocarcinoma: A Rare and Poorly Understood Neoplasm.

Gavin Low, Xu Jing Qian, Ali Ramji

|Jan 28, 2026

Not All Patients Need a CT When the Appendix Is Not Seen on Ultrasound: A Scoping Review.

Ali Ramji, Justin J Y Kim, Gavin Low

|Aug 06, 2025

Part 1: CAR Metabolic Dysfunction-Associated Steatotic Liver Disease Working Group Guidance Statements for Detecting and Grading Hepatic Steatosis Using Ultrasound, CT, or MRI.

Mitchell P Wilson, An Tang, Gavin Low

Pageof 4

Frequent Collaborators

13 joint publications

Gavin Low

Casey Hurrell

Christopher Fung

Silvia D Chang

Daisy Fung

Li Xin Zhang

Ania Kielar

Alexandra Medellin

An Tang

Andreu F Costa

Frequent Collaborators

13 joint publications

Gavin Low

4 joint publications

Casey Hurrell

4 joint publications

Christopher Fung

3 joint publications

Silvia D Chang